WASHINGTON — Novartis failed to give the government prompt, accurate reports about the deaths of dogs treated with a painkiller in the same class of medicines now linked to heart problems in humans, U.S. regulators have charged in a letter.
The problems with submissions involving the pain drug Deramaxx were among several violations of reporting require- ments for Novartis' animal drugs, the Food and Drug Administration said in the warning letter to the company.
